CNN: Inside the FDA’s reversals and walk-backs as it grapples with the coronavirus pandemic

CNN: Inside the FDA’s reversals and walk-backs as it grapples with the coronavirus pandemic. “Whether due to political pressure — a charge [Dr. Stephen]Hahn denies — or the natural burden of dealing with a global pandemic, the FDA has had to issue a number of high-profile walk-backs and revisions to its efforts to tackle Covid-19. The agency’s initially strict regulations for diagnostic test developers were removed after complaints. Its emergency authorization for hydroxychloroquine was followed by a sharp warning about deadly side effects. It issued a pullback after letting faulty antibody tests flood the market. In April it changed its guidance to allow the use of Chinese-made KN95 masks in healthcare settings, only to reverse course in May and ban many of them. There were even issues with the FDA-authorized test the White House used to screen visitors.”